Merck (MRK) reported Q4 FY 2019 earnings of $1.16 per share (versus $1.04 per share in Q4 FY 2018), beating analysts' consensus estimate of $1.15 per share.
The company's quarterly revenues amounted to $11.868 bln (+7.9% y/y), beating analysts' consensus estimate of $11.705 bln.
MRK fell to $85.60 (-3.12%) in pre-market trading.